• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外膜肺氧合使用中的出血和血栓并发症。

Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation.

机构信息

Section of Pediatric Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.

Division of Transfusion Medicine & Coagulation, Department of Pathology & Immunology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.

出版信息

Semin Thromb Hemost. 2018 Feb;44(1):20-29. doi: 10.1055/s-0037-1606179. Epub 2017 Sep 12.

DOI:10.1055/s-0037-1606179
PMID:28898902
Abstract

Extracorporeal membrane oxygenation (ECMO) has been used for >40 years to support lung and heart failure; however, bleeding and thrombosis remain serious complications. The known etiologies of bleeding include heparin effect or overdose, coagulopathy, thrombocytopenia, platelet dysfunction, acquired von Willebrand syndrome, and hyperfibrinolysis. Bleeding sites may include cannula insertion sites, recent surgical incisions, vascular access sites, lung, gastrointestinal tract, mouth, nose, thoracic cavity, abdominal cavity, and brain. Massive bleeding in the brain, the most feared bleeding complication, can be rapidly fatal because it occurs in a rigid closed space, is difficult to drain, and cannot be stopped with direct pressure to the bleeding site. Pulmonary hemorrhage may cause irreversible lung damage. Management should be swift and precise to prevent fatal bleeding. In contrast, etiologies of thrombosis include high fibrinogen and factor VIII levels, heparin resistance, and platelet activation. Achieving the optimal anticoagulation balance to prevent bleeding and thrombosis in ECMO patients is extremely complex. Experts in hemostasis should be a part of an institutional ECMO team and continuously available for immediate management.

摘要

体外膜肺氧合(ECMO)已经使用了 40 多年来支持肺和心脏衰竭;然而,出血和血栓仍然是严重的并发症。已知的出血原因包括肝素作用或过量、凝血功能障碍、血小板减少症、血小板功能障碍、获得性血管性血友病综合征和纤维蛋白溶解亢进。出血部位可能包括插管插入部位、最近的手术切口、血管通路部位、肺、胃肠道、口腔、鼻子、胸腔、腹腔和大脑。大脑的大量出血是最可怕的出血并发症,因为它发生在一个刚性的封闭空间,难以引流,不能通过直接按压出血部位来止血,因此可能会迅速致命。肺出血可能导致不可逆转的肺损伤。管理应该迅速而精确,以防止致命性出血。相比之下,血栓形成的原因包括纤维蛋白原和因子 VIII 水平升高、肝素抵抗和血小板激活。在 ECMO 患者中实现预防出血和血栓形成的最佳抗凝平衡极其复杂。止血专家应成为机构 ECMO 团队的一部分,并随时可供立即管理。

相似文献

1
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation.体外膜肺氧合使用中的出血和血栓并发症。
Semin Thromb Hemost. 2018 Feb;44(1):20-29. doi: 10.1055/s-0037-1606179. Epub 2017 Sep 12.
2
Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.仅采用预防性皮下抗凝的静脉-静脉体外膜肺氧合:一项针对60多名患者的观察性研究。
Artif Organs. 2017 Feb;41(2):186-192. doi: 10.1111/aor.12737. Epub 2016 Jun 3.
3
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation.体外循环及体外膜肺氧合中体外循环回路的止血管理。
Semin Thromb Hemost. 2020 Feb;46(1):62-72. doi: 10.1055/s-0039-3400273. Epub 2019 Dec 13.
4
Extracorporeal membrane oxygenation-hemostatic complications.体外膜肺氧合-止血并发症
Transfus Med Rev. 2015 Apr;29(2):90-101. doi: 10.1016/j.tmrv.2014.12.001. Epub 2014 Dec 18.
5
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.COVID-19 患者在体外膜肺氧合(ECMO)治疗期间的管理:注意获得性血管性血友病。
J Atheroscler Thromb. 2021 Apr 1;28(4):396-401. doi: 10.5551/jat.58362. Epub 2020 Oct 28.
6
Anticoagulation practices associated with bleeding and thrombosis in pediatric extracorporeal membrane oxygenation; a multi-center secondary analysis.儿科体外膜肺氧合中与出血和血栓形成相关的抗凝实践;一项多中心二次分析。
Perfusion. 2023 Mar;38(2):363-372. doi: 10.1177/02676591211056562. Epub 2022 Feb 27.
7
Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.体外膜肺氧合支持下的重症 COVID-19 患者的出血和血栓事件:一项全国性队列研究。
Intensive Care Med. 2022 Aug;48(8):1039-1052. doi: 10.1007/s00134-022-06794-y. Epub 2022 Jul 13.
8
Optimal Tests to Minimise Bleeding and Ischaemic Complications in Patients on Extracorporeal Membrane Oxygenation.优化体外膜肺氧合患者的出血和缺血并发症的检测方法。
Thromb Haemost. 2022 Apr;122(4):480-491. doi: 10.1055/a-1508-8230. Epub 2021 Jun 21.
9
Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors.29例小儿体外膜肺氧合治疗死亡病例中血栓形成和出血的实验室及临床预测因素
Pediatr Dev Pathol. 2010 Sep-Oct;13(5):385-92. doi: 10.2350/09-09-0704-OA.1. Epub 2010 Jan 19.
10
Aminocaproic acid for the management of bleeding in patients on extracorporeal membrane oxygenation: Four adult case reports and a review of the literature.氨基己酸用于体外膜肺氧合患者出血的管理:4例成人病例报告及文献综述
Heart Lung. 2016 May-Jun;45(3):232-6. doi: 10.1016/j.hrtlng.2016.01.011. Epub 2016 Feb 20.

引用本文的文献

1
Extracorporeal life support for adult patients with ARDS.成人急性呼吸窘迫综合征患者的体外生命支持
Intensive Care Med. 2025 Aug 6. doi: 10.1007/s00134-025-08070-1.
2
The Novel Application of Surgiflo and Successful Hemostasis of Refractory Intrapulmonary Hemorrhage in Extracorporeal Membrane Oxygenation.Surgiflo的新应用及体外膜肺氧合中难治性肺内出血的成功止血
Crit Care Explor. 2025 Aug 6;7(8):e1301. doi: 10.1097/CCE.0000000000001301. eCollection 2025 Aug 1.
3
Prolonged ECMO Management (124 Days) in a Severe COVID-19 Patient Complicated by Acute Myocardial Infarction and Thrombocytopenia: A Case Report.
一名重症 COVID-19 患者合并急性心肌梗死和血小板减少症的长期体外膜肺氧合治疗(124 天):病例报告
Infect Drug Resist. 2025 Jul 1;18:3247-3255. doi: 10.2147/IDR.S511482. eCollection 2025.
4
Citrate regional anticoagulation of 500 ml/min of extracorporeal blood flow: an experimental study.体外血流速度为500毫升/分钟时的枸橼酸盐局部抗凝:一项实验研究。
Intensive Care Med Exp. 2025 Jun 24;13(1):64. doi: 10.1186/s40635-025-00771-7.
5
Analysis of the feasibility of a low-anticoagulation strategy in patients undergoing post-cardiotomy extracorporeal membrane oxygenation: a retrospective cohort study.心脏术后体外膜肺氧合患者低抗凝策略的可行性分析:一项回顾性队列研究
BMC Anesthesiol. 2025 May 30;25(1):275. doi: 10.1186/s12871-025-03153-4.
6
Risk factors for invasive mechanical ventilation, extracorporeal membrane oxygenation, and mortality in children with severe adenovirus infection in the pediatric intensive care unit: a retrospective study.儿科重症监护病房中重症腺病毒感染患儿有创机械通气、体外膜肺氧合及死亡的危险因素:一项回顾性研究
BMC Pediatr. 2025 Apr 28;25(1):331. doi: 10.1186/s12887-025-05461-7.
7
foot protein mimics for tailoring long-acting endothelium-mimicking anti-thrombotic surfaces.用于定制长效内皮模拟抗血栓表面的足部蛋白模拟物。
Bioact Mater. 2025 Apr 1;50:1-13. doi: 10.1016/j.bioactmat.2025.03.019. eCollection 2025 Aug.
8
Extracorporeal Membrane Oxygenation for Treatment of Immune Checkpoint Inhibitor-Related Pneumonia Complicated with Severe ARDS: A Case Report.体外膜肺氧合治疗免疫检查点抑制剂相关肺炎合并重症急性呼吸窘迫综合征:一例报告
Int Med Case Rep J. 2025 Mar 26;18:411-419. doi: 10.2147/IMCRJ.S507273. eCollection 2025.
9
A Retrospective Analysis of the Effects of Concomitant Use of Intra-Aortic Balloon Pump (IABP) and Veno-Arterial Extracorporeal Membrane Oxygenation (va-ECMO) Therapy on Procedural Brain Infarction.主动脉内球囊反搏(IABP)与静脉-动脉体外膜肺氧合(va-ECMO)联合使用对手术相关脑梗死影响的回顾性分析
Diagnostics (Basel). 2025 Mar 12;15(6):699. doi: 10.3390/diagnostics15060699.
10
Anticoagulation Management During ECMO: Narrative Review.体外膜肺氧合期间的抗凝管理:叙述性综述
JHLT Open. 2025 Jan 20;8:100216. doi: 10.1016/j.jhlto.2025.100216. eCollection 2025 May.